Co-occurring Mental Disorders in Transitional Aged Youth With Substance Use Disorders - A Narrative Review

Overview

Journal Front Psychiatry

Specialty Psychiatry

Date 2022 Mar 14

PMID 35280170

Authors

Patrick Kock

Maximilian Meyer

Julie Elsner

Kenneth M Dursteler

Marc Vogel

Marc Walter

Affiliations

Soon will be listed here.

Abstract

Adolescence and emerging adulthood are often referred to as youth. Transitional psychiatry addresses this target group, which considers patients between 15 and 25 years of age. Substance use usually begins and peaks at this stage of life. Psychiatric disorders, foremost attention-deficit/hyperactivity disorder, and affective disorders, conduct disorders, and first-episodes psychosis frequently appear in early life stages. This review aims to provide a broad overview of transitional-aged youth's most common psychiatric comorbidities with substance use disorders. A literature search was conducted in Embase and Pubmed, and the main findings are described narratively. We present main findings for the following comorbidities: attention-deficit/hyperactivity disorder, conduct disorder, personality disorders, affective disorders, psychotic disorders, and the phenomena of overdose and suicidality. In conclusion, co-occurring mental health disorders are common and appear to facilitate the development of substance use disorders and exacerbate their overall course. Substance use also affects the severity and course of comorbid psychiatric disorders. Overall, data on transition-age youth with substance use disorders are highly inconsistent. Universal screening and treatment guidelines do not yet exist but should be aimed for in the future.

Citing Articles

Editors' Best of 2023.

Althoff R, Bagot K, Dickstein D, Drury S, Findling R, Singh M JAACAP Open. 2024; 2(1):1-5.

PMID: 39554699 PMC: 11562428. DOI: 10.1016/j.jaacop.2024.01.001.

Adverse childhood experiences and risk of suicide and substance-related mortality through middle adulthood.

Govender T, Vidal-Ribas P, Yu J, Haynie D, Augustin D, Gilman S J Affect Disord. 2024; 369:1201-1208.

PMID: 39490671 PMC: 11786963. DOI: 10.1016/j.jad.2024.10.085.

Family-centred interventions for people with substance use disorders in low-income and middle-income country settings: a scoping review protocol.

Sharma A, Mita C, Kumar S, Mayer K, OCleirigh C, Solomon S BMJ Open. 2024; 14(8):e087560.

PMID: 39209780 PMC: 11367307. DOI: 10.1136/bmjopen-2024-087560.

Substance use and its association with mental health among Swiss medical students: A cross-sectional study.

Gaume J, Carrard V, Berney S, Bourquin C, Berney A Int J Soc Psychiatry. 2024; 70(4):808-817.

PMID: 38420921 PMC: 11144353. DOI: 10.1177/00207640241232321.

The Counterproductive Effect of Right Anodal/Left Cathodal Transcranial Direct Current Stimulation Over the Dorsolateral Prefrontal Cortex on Impulsivity in Methamphetamine Addicts.

Jiang X, Tian Y, Zhang Z, Zhou C, Yuan J Front Psychiatry. 2022; 13:915440.

PMID: 35815052 PMC: 9257135. DOI: 10.3389/fpsyt.2022.915440.

References

Lindhiem O, Bennett C, Hipwell A, Pardini D . Beyond Symptom Counts for Diagnosing Oppositional Defiant Disorder and Conduct Disorder?. J Abnorm Child Psychol. 2015; 43(7):1379-87. PMC: 4561600. DOI: 10.1007/s10802-015-0007-x. View

Castellanos D, Kosoy J, Diaz Ayllon K, Acuna J . Presence of Alcohol and Drugs in Hispanic Versus Non-Hispanic Youth Suicide Victims in Miami-Dade County, Florida. J Immigr Minor Health. 2016; 18(5):1024-1031. DOI: 10.1007/s10903-016-0418-y. View

Wilens T, Faraone S, Biederman J, Gunawardene S . Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003; 111(1):179-85. DOI: 10.1542/peds.111.1.179. View

Mack K, Jones C, Ballesteros M . Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas - United States. MMWR Surveill Summ. 2017; 66(19):1-12. PMC: 5829955. DOI: 10.15585/mmwr.ss6619a1. View

Ottosen C, Larsen J, Faraone S, Chen Q, Hartman C, Larsson H . Sex Differences in Comorbidity Patterns of Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2019; 58(4):412-422.e3. DOI: 10.1016/j.jaac.2018.07.910. View

Arnett J . Emerging adulthood. A theory of development from the late teens through the twenties. Am Psychol. 2000; 55(5):469-80. View

Border R, Corley R, Brown S, Hewitt J, Hopfer C, McWilliams S . Independent predictors of mortality in adolescents ascertained for conduct disorder and substance use problems, their siblings and community controls. Addiction. 2018; 113(11):2107-2115. PMC: 6175651. DOI: 10.1111/add.14366. View

Jones P . Adult mental health disorders and their age at onset. Br J Psychiatry Suppl. 2013; 54:s5-10. DOI: 10.1192/bjp.bp.112.119164. View

Sihvola E, Rose R, Dick D, Pulkkinen L, Marttunen M, Kaprio J . Early-onset depressive disorders predict the use of addictive substances in adolescence: a prospective study of adolescent Finnish twins. Addiction. 2008; 103(12):2045-53. PMC: 2693250. DOI: 10.1111/j.1360-0443.2008.02363.x. View

10.

Henggeler S, Schaeffer C . Multisystemic Therapy(®) : Clinical Overview, Outcomes, and Implementation Research. Fam Process. 2016; 55(3):514-28. DOI: 10.1111/famp.12232. View

11.

Gilder D, Ehlers C . Depression symptoms associated with cannabis dependence in an adolescent American Indian community sample. Am J Addict. 2012; 21(6):536-43. PMC: 3498983. DOI: 10.1111/j.1521-0391.2012.00281.x. View

12.

Deas D . Adolescent substance abuse and psychiatric comorbidities. J Clin Psychiatry. 2006; 67 Suppl 7:18-23. View

13.

Semple D, McIntosh A, Lawrie S . Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol. 2005; 19(2):187-94. DOI: 10.1177/0269881105049040. View

14.

Degenhardt L, Coffey C, Moran P, Carlin J, Patton G . The predictors and consequences of adolescent amphetamine use: findings from the Victoria Adolescent Health Cohort Study. Addiction. 2007; 102(7):1076-84. DOI: 10.1111/j.1360-0443.2007.01839.x. View

15.

Moffitt T . Juvenile delinquency and attention deficit disorder: boys' developmental trajectories from age 3 to age 15. Child Dev. 1990; 61(3):893-910. DOI: 10.1111/j.1467-8624.1990.tb02830.x. View

16.

Aseltine Jr R, Schilling E, James A, Glanovsky J, Jacobs D . Age variability in the association between heavy episodic drinking and adolescent suicide attempts: findings from a large-scale, school-based screening program. J Am Acad Child Adolesc Psychiatry. 2009; 48(3):262-270. DOI: 10.1097/CHI.0b013e318195bce8. View

17.

Van Horn D, Frank A . Substance-use situations and abstinence predictions in substance abusers with and without personality disorders. Am J Drug Alcohol Abuse. 1998; 24(3):395-404. DOI: 10.3109/00952999809016905. View

18.

Wilens T . Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry. 2004; 65 Suppl 3:38-45. View

19.

Volkow N, Swanson J . Does childhood treatment of ADHD with stimulant medication affect substance abuse in adulthood?. Am J Psychiatry. 2008; 165(5):553-5. PMC: 2667111. DOI: 10.1176/appi.ajp.2008.08020237. View

20.

Bornovalova M, Hicks B, Iacono W, McGue M . Longitudinal twin study of borderline personality disorder traits and substance use in adolescence: developmental change, reciprocal effects, and genetic and environmental influences. Personal Disord. 2012; 4(1):23-32. PMC: 3435491. DOI: 10.1037/a0027178. View